Fees' and emoluments' entitlement of the two executive directors of the Company shall not exceed in aggregate an amount of HK$8,000,000 per annum. 

The Company is committed to propose to the shareholders at annual general meetings to issue and allot new shares up to 10% of the issued share capital of the Company. The Company is also committed not to issue any shares pursuant to the general mandate at a discount of more than 12% to the benchmarked price (as defined in Rule 13.36(5) of the Listing Rules), unless approved by an independent Board committee.

The Company will ensure that the aggregate of all connected transactions over any 12-month period not exceeding HK$500 million unless approved by the independent shareholders. 

The number of Independent Non-executive Directors of the Company will not be less than 50% of the total number of Directors of the Company. 

Corporate Governance Report   PDF